Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
Alessio De Rose, Nutrition Manager at S.S. Lazio, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nutrients, adding:
“I am thrilled to share our recently published article in Nutrients:
‘Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency’
Incretin receptor agonist-based therapies, including GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists, have significantly changed the management of type 2 diabetes, overweight, and obesity.
As their clinical use continues to expand, it is becoming increasingly important to consider not only their metabolic benefits, but also their potential nutritional implications.
In this perspective article, we discuss emerging evidence on the possible association between incretin-based therapies and iron deficiency/iron deficiency anemia, explore the potential underlying mechanisms, and propose practical strategies for prevention, biochemical monitoring, and clinical-nutritional management.
This work highlights the importance of integrating pharmacological innovation with careful nutritional assessment and individualized patient care.
I am grateful to all co-authors and collaborators for their valuable contribution to this work.”
Title: Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency
Authors: Marco Infante, Camillo Ricordi, Francesca Pacifici, Donatella Pastore, Raffaele Infante, Massimiliano Caprio, Francesca Chiereghin, Alessandro De Stefano, Giulia Frank, Alessio De Rose, Lorenzo Romano, Laura Di Renzo, Valentina Rovella, Antonino De Lorenzo, Giulia Donadel, David Della-Morte

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience
-
Nov 12, 2026, 22:46Ashish Sharma: In-Hospital Mortality and Bleeding Complications in APL
-
Nov 12, 2026, 22:44Mary Cushman: New Position at the Vermont Center for Cardiovascular and Brain Health
-
Nov 12, 2026, 22:43Lama Alstanbuli: Discussing and Optimizing Stroke Pathways Across Healthcare Systems
-
Nov 12, 2026, 22:35Carmen’s Recovery From Spontaneous Coronary Artery Dissection – American Heart Association
-
Nov 12, 2026, 22:34What’s Next in Comprehensive Care for Hemophilia and Other Bleeding Disorders? – WFH